ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,328Medicare Part D Prescriptions Filled, Including Refills

Rank: 135 out of 625

$469K Total Retail Price of All Prescriptions

Rank: 199 out of 625

430 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 430 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 430 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 6,693 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
SIMVASTATIN 457 359 1 2
AMLODIPINE BESYLATE 368 309 2 1
FUROSEMIDE 337 234 3 7
HYDROCODONE-ACETAMINOPHEN 303 202 S3 4 4
LEVOTHYROXINE SODIUM 266 223 5 3
METFORMIN HCL 255 183 6 10
TRAMADOL HCL 227 127 7 16
LISINOPRIL 177 116 8 5
OMEPRAZOLE 170 115 9 6
BENAZEPRIL HCL 166 129 10 35
MELOXICAM 140 110 11 31
METOPROLOL TARTRATE 126 102 12 11
GLIPIZIDE 118 71 13 56
DONEPEZIL HCL 111 104 14 33
METOPROLOL SUCCINATE 108 77 15 15
ZOLPIDEM TARTRATE 105 79 16 13
POTASSIUM CHLORIDE 103 48 17 19
ALENDRONATE SODIUM 100 85 18 34
JANUVIA 95 60 19 74
CYCLOBENZAPRINE HCL 89 40 R 20 65
WARFARIN SODIUM 84 74 21 20
LANTUS SOLOSTAR 82 40 22 85
NEXIUM 80 43 23 21
CLONIDINE HCL 77 58 24 50
LOSARTAN POTASSIUM 77 76 24 18
ATORVASTATIN CALCIUM 76 50 26 9
PREDNISONE 76 58 26 37
HYDROCHLOROTHIAZIDE 76 50 26 12
CIPROFLOXACIN HCL 76 63 26 60
GABAPENTIN 72 36 30 14
LEVOFLOXACIN 72 52 30 90
SERTRALINE HCL 71 58 32 26
CLOPIDOGREL 71 70 32 30
PRAVASTATIN SODIUM 71 50 32 8
LOVASTATIN 71 16 32 58
FLUTICASONE PROPIONATE 70 39 36 32
CARVEDILOL 69 33 37 23
ATENOLOL 69 56 37 22
OXYCODONE-ACETAMINOPHEN 67 30 S2 39 95
GEMFIBROZIL 63 44 40 127
TAMSULOSIN HCL 62 61 41 36
NAMENDA 62 62 41 45
SPIRIVA 61 39 43 70
AZITHROMYCIN 61 39 43 40
PLAVIX 60 57 45 43
DIGOXIN 59 59 46 55
PAROXETINE HCL 57 41 47 76
CEFUROXIME 57 39 47 161
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 50 47 27
RAMIPRIL 56 35 50 78
DIOVAN 55 49 51 28
LOSARTAN-HYDROCHLOROTHIAZIDE 55 55 51 38
PRAMIPEXOLE DIHYDROCHLORIDE 53 40 53 208
RANITIDINE HCL 50 33 54 25
TRAZODONE HCL 50 19 54 51
PANTOPRAZOLE SODIUM 50 49 54 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 26, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.